Conversely, pharmacological blockade of TLR4 activity tended to decrease the effect of NASH fEVs on IL‐6, IL‐8, CCL2 and CXCL1 production in endothelial cells. Here, CXCL8 is linked to metabolic dysfunction-associated steatohepatitis.